MARKET

TOVX

TOVX

THERIVA BIOLOGICS INC
AMEX
1.490
+0.010
+0.68%
Opening 12:01 01/21 EST
OPEN
1.540
PREV CLOSE
1.480
HIGH
1.540
LOW
1.480
VOLUME
11.32K
TURNOVER
--
52 WEEK HIGH
17.11
52 WEEK LOW
1.140
MARKET CAP
4.15M
P/E (TTM)
-0.0821
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at TOVX last week (0113-0117)?
Weekly Report · 2d ago
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga · 6d ago
Theriva Biologics Has Received A Decision to Grant European Patent Number EP3965804 Titled "Beta-Lactamase Compositions For Treatment Of Graft Versus Host Disease"
Benzinga · 01/14 20:53
Weekly Report: what happened at TOVX last week (0106-0110)?
Weekly Report · 01/13 09:45
Weekly Report: what happened at TOVX last week (1230-0103)?
Weekly Report · 01/06 09:48
Weekly Report: what happened at TOVX last week (1223-1227)?
Weekly Report · 12/30/2024 09:46
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga · 12/26/2024 21:05
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga · 12/24/2024 21:06
More
About TOVX
Theriva Biologics, Inc. is a diversified clinical-stage company developing therapeutics designed to treat cancer and related diseases in areas of high unmet need. It is advancing a new oncolytic adenovirus platform. Its candidates are VCN-01, SYN-004 (ribaxamase) and SYN-020. VCN-01 is an oncolytic adenovirus designed to replicate selectively and aggressively within tumor cells, and to degrade the tumor stroma barrier that serves as a significant physical and immunosuppressive barrier to cancer treatment. SYN-004 (ribaxamase) is designed to degrade certain commonly used intravenous beta-lactam antibiotics within the gastrointestinal (GI) tract to prevent microbiome damage. SYN-020 is a recombinant oral formulation of the enzyme intestinal alkaline phosphatase produced under current good manufacturing practice conditions and intended to treat both local GI and systemic diseases. Its research programs include VCN-11 Albumin Shield Technology and SYN-006, SYN-007, other oncolytic virus.

Webull offers Theriva Biologics Inc stock information, including AMEX: TOVX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TOVX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TOVX stock methods without spending real money on the virtual paper trading platform.